FRACTYL HEALTH, INC. (GUTS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
GUTS currently has 158M outstanding shares. with moderate dilution risk from 64.1M authorized shares representing 40.4% potential dilution. The company has significantly diluted shareholders by 197.91% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
10-Q filing | 158.5M shares outstanding |
160M | 64M |
| Mar 24, 2026 |
10-K filing | 158.6M shares outstanding |
160M | 64M |
| Nov 12, 2025 |
10-Q filing | 137.0M shares outstanding |
140M | 64M |
| Aug 12, 2025 |
10-Q filing | 49.0M shares outstanding |
49M | 64M |
| May 13, 2025 |
10-Q filing | 48.9M shares outstanding |
49M | 64M |
| Mar 13, 2025 |
S-3/A filing: Fractyl Health, Inc. is offering up to $300,000,000 in the aggregate of common stock, preferred stock, and debt securities from time to time in one or more offerings. |
49M | 64M |
| Mar 03, 2025 |
10-K filing | 48.9M shares outstanding |
49M | 64M |
| Mar 03, 2025 |
S-3 filing: Fractyl Health, Inc. is offering and selling up to $300,000,000 in the aggregate of common stock, preferred stock, and debt securities. |
49M | 64M |
| Nov 12, 2024 |
10-Q filing | 48.0M shares outstanding |
48M | 0 |
| Aug 14, 2024 |
10-Q filing | 47.9M shares outstanding |
48M | 0 |
| May 13, 2024 |
10-Q filing | 47.9M shares outstanding |
48M | 0 |
| Dec 14, 2023 |
S-1 filing: The company issued warrants to purchase shares of common stock in connection with the issuance of amended and restated convertible notes. |
N/A | 0 |